ERBB2 and neoplasm: More strikingly, lapatinib can effectively block the MMTV-HER2 tumor lung metastasis in vivo, but MMTV-HER2/MMTV-MED1 tumors metastasize to lung even with lapatinib treatment and, again, as efficiently as the vehicle control-treated MMTV-HER2 group.